These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14705204)

  • 21. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.
    Youn YS; Jung JY; Oh SH; Yoo SD; Lee KC
    J Control Release; 2006 Sep; 114(3):334-42. PubMed ID: 16884808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
    Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
    J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
    Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
    Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
    Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill®) of salmon calcitonin.
    Aguirre TA; Rosa M; Coulter IS; Brayden DJ
    Eur J Pharm Sci; 2015 Nov; 79():102-11. PubMed ID: 26349051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
    du Plessis LH; Lubbe J; Strauss T; Kotzé AF
    Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes.
    Cheng WP; Thompson C; Ryan SM; Aguirre T; Tetley L; Brayden DJ
    J Control Release; 2010 Oct; 147(2):289-97. PubMed ID: 20705108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery.
    Prego C; Fabre M; Torres D; Alonso MJ
    Pharm Res; 2006 Mar; 23(3):549-56. PubMed ID: 16525861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of processing parameters on the properties of peptide-containing PLGA microspheres.
    Jeyanthi R; Mehta RC; Thanoo BC; DeLuca PP
    J Microencapsul; 1997; 14(2):163-74. PubMed ID: 9132468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
    Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
    Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.
    Lee YH; Perry BA; Sutyak JP; Stern W; Sinko PJ
    Pharm Res; 2000 Mar; 17(3):284-90. PubMed ID: 10801216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin.
    Sakuma S; Suzuki N; Sudo R; Hiwatari K; Kishida A; Akashi M
    Int J Pharm; 2002 Jun; 239(1-2):185-95. PubMed ID: 12052704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine.
    Sakuma S; Sudo R; Suzuki N; Kikuchi H; Akashi M; Ishida Y; Hayashi M
    J Control Release; 2002 Jun; 81(3):281-90. PubMed ID: 12044567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained release of salmon calcitonin in vivo from lactide: glycolide copolymer depots.
    Millest AJ; Evans JR; Young JJ; Johnstone D
    Calcif Tissue Int; 1993 May; 52(5):361-4. PubMed ID: 8504374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
    Fan T; Chen C; Guo H; Xu J; Zhang J; Zhu X; Yang Y; Zhou Z; Li L; Huang Y
    Eur J Pharm Biopharm; 2014 Oct; 88(2):518-28. PubMed ID: 24968819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.